Literature DB >> 21899441

Frequency Determination of α-1,3 Glucosyltransferase p.Y131H and p.F304S Polymorphisms in the Croatian Population Revealed Five Novel Single Nucleotide Polymorphisms in the hALG6 Gene.

Sandra Supraha Goreta1, Sanja Dabelic, Dinko Pavlinic, Gordan Lauc, Jerka Dumic.   

Abstract

The congenital disorder of glycosylation (CDG)-Ic (ALG6-CDG, CDG-Ic) is caused by mutations in the hALG6 gene that encodes the N-glycosylation pathway enzyme, α-1,3-glucosyltransferase (NP_037471.2). The aim of our study was to estimate the frequencies of ALG6-CDG related p.Y131H and p.F304S polymorphisms in the Croatian population. Genomic DNA was isolated from blood samples collected from 600 healthy individuals. Functional single-nucleotide polymorphisms rs35383149 and rs17856039 causing p.Y131H and p.F304S, respectively, were genotyped by the TaqMan method and direct sequencing. The frequency of p.F304S polymorphism in the studied cohort was shown to be similar to the frequencies found in other tested populations (27%), whereas the frequency of p.Y131H was found to be three times higher (6.7%). Five novel base substitutions in the hALG6 gene were also found: three in exon 5 (c.383T>C, c.390G>A, and c.429G>C) and two in a downstream intervening sequence (IVS5+17C/T and IVS5+34G/A).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21899441      PMCID: PMC3265770          DOI: 10.1089/gtmb.2011.0093

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  20 in total

1.  Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).

Authors:  E Schollen; S Kjaergaard; E Legius; M Schwartz; G Matthijs
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

2.  The T911C (F304S) substitution in the human ALG6 gene is a common polymorphism and not a causal mutation of CDG-Ic.

Authors:  S Vuillaumier-Barrot; C Le Bizec; G Durand; N Seta
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

Review 3.  Update and perspectives on congenital disorders of glycosylation.

Authors:  H H Freeze
Journal:  Glycobiology       Date:  2001-12       Impact factor: 4.313

Review 4.  Congenital disorders of glycosylation (CDG): it's (nearly) all in it!

Authors:  Jaak Jaeken
Journal:  J Inherit Metab Dis       Date:  2011-03-08       Impact factor: 4.982

5.  Clinical and biochemical characteristics of congenital disorder of glycosylation type Ic, the first recognized endoplasmic reticulum defect in N-glycan synthesis.

Authors:  S Grünewald; T Imbach; K Huijben; M E Rubio-Gozalbo; A Verrips; J B de Klerk; H Stroink; J F de Rijk-van Andel; J L Van Hove; U Wendel; G Matthijs; T Hennet; J Jaeken; R A Wevers
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

6.  Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic.

Authors:  T Imbach; S Grünewald; B Schenk; P Burda; E Schollen; R A Wevers; J Jaeken; J B de Klerk; E G Berger; G Matthijs; M Aebi; T Hennet
Journal:  Hum Genet       Date:  2000-05       Impact factor: 4.132

Review 7.  Balancing N-linked glycosylation to avoid disease.

Authors:  H H Freeze; V Westphal
Journal:  Biochimie       Date:  2001-08       Impact factor: 4.079

8.  A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.

Authors:  Vibeke Westphal; Susanne Kjaergaard; Els Schollen; Kevin Martens; Stephanie Grunewald; Marianne Schwartz; Gert Matthijs; Hudson H Freeze
Journal:  Hum Mol Genet       Date:  2002-03-01       Impact factor: 6.150

9.  Congenital disorder of glycosylation Ic in patients of Indian origin.

Authors:  J W Newell; N-S Seo; G M Enns; M McCraken; J F Mantovani; H H Freeze
Journal:  Mol Genet Metab       Date:  2003-07       Impact factor: 4.797

Review 10.  Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies.

Authors:  T Marquardt; J Denecke
Journal:  Eur J Pediatr       Date:  2003-03-15       Impact factor: 3.183

View more
  3 in total

1.  ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies.

Authors:  Eva Morava; Vera Tiemes; Christian Thiel; Nathalie Seta; Pascale de Lonlay; Hans de Klerk; Margot Mulder; Estela Rubio-Gozalbo; Gepke Visser; Peter van Hasselt; Dafne D G Horovitz; Carolina Fischinger Moura de Souza; Ida V D Schwartz; Andrew Green; Mohammed Al-Owain; Graciella Uziel; Sabine Sigaudy; Brigitte Chabrol; Franc-Jan van Spronsen; Martin Steinert; Eleni Komini; Donald Wurm; Andrea Bevot; Addelkarim Ayadi; Karin Huijben; Marli Dercksen; Peter Witters; Jaak Jaeken; Gert Matthijs; Dirk J Lefeber; Ron A Wevers
Journal:  J Inherit Metab Dis       Date:  2016-06-10       Impact factor: 4.982

Review 2.  Insights into complexity of congenital disorders of glycosylation.

Authors:  Sandra Supraha Goreta; Sanja Dabelic; Jerka Dumic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

3.  A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity.

Authors:  S Sabry; S Vuillaumier-Barrot; E Mintet; M Fasseu; V Valayannopoulos; D Héron; N Dorison; C Mignot; N Seta; I Chantret; T Dupré; S E H Moore
Journal:  Orphanet J Rare Dis       Date:  2016-06-24       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.